tPA-PAl (tissue plasminogen activator—plasminogen activator inhibitor-1 complex) can be a predictive marker of multiple organ dysfunction syndrome in seriously ill acute patients with glucose intolerance — analysis under strict blood gluco

M Hoshino; Y Haraguchi; M Sakai; H Saegusa; E Hayashi; N Horita; H Ohsawa

首页> 外文期刊>Critical care : >tPA-PAl (tissue plasminogen activator—plasminogen activator inhibitor-1 complex) can be a predictive marker of multiple organ dysfunction syndrome in seriously ill acute patients with glucose intolerance — analysis under strict blood gluco

【24h】

tPA-PAl (tissue plasminogen activator—plasminogen activator inhibitor-1 complex) can be a predictive marker of multiple organ dysfunction syndrome in seriously ill acute patients with glucose intolerance — analysis under strict blood gluco

机译：tPA-PA1（组织型纤溶酶原激活物-纤溶酶原激活物抑制剂-1复合物）可以作为重症急性葡萄糖耐量异常患者多器官功能障碍综合征的预测指标—在严格的血糖控制下进行分析

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Critical care :》 |1999年第1期|共页
作者
M Hoshino; Y Haraguchi; M Sakai; H Saegusa; E Hayashi; N Horita; H Ohsawa;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类护理学;
关键词

相似文献

外文文献
中文文献
专利

1. Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas [J] . Masami Hoshino, Yoshikura Haraguchi, Hiroyuki Hirasawa, Critical care : . 2001,第2期

机译：用人工胰腺研究组织纤溶酶原激活物-纤溶酶原激活物抑制剂-1复合物与多器官功能障碍综合征的密切关系
2. Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke. [J] . Johansson L, Jansson JH, Boman K, Stroke: A Journal of Cerebral Circulation . 2000,第1期

机译：组织纤溶酶原激活物，纤溶酶原激活物抑制剂-1和组织纤溶酶原激活物/纤溶酶原激活物抑制剂-1复合物是发生中风的危险因素。
3. Close relationship of PAI-1 (plasminogen activator inhibitor-1) with multiple organ dysfunction syndrome and abnormal glucose metabolism investigated by means of artificial pancreas [J] . M Hoshino, Y Haraguchi, M Sakai, Critical care : . 1998,第Suppla1期

机译：用人工胰腺检查PAI-1（纤溶酶原激活物抑制剂-1）与多器官功能障碍综合征和葡萄糖代谢异常之间的密切关系
4. Laser thrombolysis and in vitro study of Tissue Plasminogen Activators (tPA) Release Encapsulated by Chitosan Coated PLGA Nanoparticles for acute myocardial infarction (AMI) [C] . Mahboobeh Mahmoodi, Mohammad E. Khosroshahi, Fatemeh Atyabi Proceedings of the world medical conference . 2010

机译：激光溶栓和壳聚糖涂层PLGA纳米颗粒包裹的组织纤溶酶原激活剂（tPA）释放的体外研究用于急性心肌梗死（AMI）
5. A structure-function analysis of the lysine-binding kringle 2 domains of human tissue-type plasminogen activator and human plasminogen by strategic mutagenesis. [D] . Nilsen, Stephanie Lynn. 1999

机译：通过战略诱变对人体组织型纤溶酶原激活物和纤溶酶原的赖氨酸结合kringle 2域的结构功能分析。
6. tPA-PAl (tissue plasminogen activator—plasminogen activator inhibitor-1 complex) can be a predictive marker of multiple organ dysfunction syndrome in seriously ill acute patients with glucose intolerance — analysis under strict blood glucose control by artificial pancreas [O] . M Hoshino, Y Haraguchi, M Sakai, 1999

机译：tPA-PA1（组织型纤溶酶原激活物-纤溶酶原激活物抑制剂-1复合物）可以作为重症急性葡萄糖耐量异常患者多器官功能不全综合征的预测指标-在严格控制血糖的情况下通过人工胰腺进行分析
7. tPA-PAl (tissue plasminogen activator—plasminogen activator inhibitor-1 complex) can be a predictive marker of multiple organ dysfunction syndrome in seriously ill acute patients with glucose intolerance — analysis under strict blood glucose control by artificial pancreas [O] . Hoshino, M, Haraguchi, Y, Sakai, M, 1999

机译：tPA-PA1（组织纤溶酶原激活物-纤溶酶原激活物抑制剂-1复合物）可以作为重症急性葡萄糖耐量异常患者多器官功能不全综合征的预测标志物-在人工胰腺严格控制血糖的情况下进行分析

tPA-PAl (tissue plasminogen activator—plasminogen activator inhibitor-1 complex) can be a predictive marker of multiple organ dysfunction syndrome in seriously ill acute patients with glucose intolerance — analysis under strict blood gluco

著录项

相似文献

相关主题

期刊订阅